Wound Complications in Head and Neck Squamous Cell Carcinomas After Anti–PD-1 Therapy

Victoria Hwang, Eduardo Mendez, Laura Q.M. Chow, Neal David Futran, Peter Andersen, Ryan Li, Vasu Divi, Cristina P. Rodriguez

Research output: Contribution to journalArticle

Abstract

Immune checkpoint inhibitors have demonstrated activity in recurrent/metastatic head and neck squamous cell cancer, but less is known regarding their long-term sequelae. We describe four patients who, after complete responses to anti–PD-1 therapy, developed complications requiring surgical intervention. Patient 1 is a 57-year-old female whose marked tumor regression exposed some mandibular hardware. Patient 2 is a 39-year-old male who developed an ulcerated buccal lesion with exposed mandible. Patient 3 is a 66-year-old male with craniofacial osteoradionecrosis. Patient 4 is a 71-year-old male who developed an exposed and fractured mandible. All patients successfully underwent surgical intervention and remain disease free. Laryngoscope, 129:E428–E433, 2019.

Original languageEnglish (US)
Pages (from-to)E428-E433
JournalLaryngoscope
Volume129
Issue number12
DOIs
StatePublished - Dec 1 2019

Keywords

  • Head and neck cancer
  • checkpoint inhibitors
  • head and neck squamous cell carcinoma
  • immunotherapy
  • monoclonal antibodies
  • osteoradionecrosis

ASJC Scopus subject areas

  • Otorhinolaryngology

Fingerprint Dive into the research topics of 'Wound Complications in Head and Neck Squamous Cell Carcinomas After Anti–PD-1 Therapy'. Together they form a unique fingerprint.

  • Cite this

    Hwang, V., Mendez, E., Chow, L. Q. M., Futran, N. D., Andersen, P., Li, R., Divi, V., & Rodriguez, C. P. (2019). Wound Complications in Head and Neck Squamous Cell Carcinomas After Anti–PD-1 Therapy. Laryngoscope, 129(12), E428-E433. https://doi.org/10.1002/lary.27902